Which has the lower trailing P/E, DVA or ZBH?

DVA has the lower trailing P/E: DVA trades at 23.51 and ZBH at 25.19. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, DVA or ZBH?

Over the past five years, ZBH grew revenue faster — DVA at a 3.71% CAGR versus ZBH at 4.21%.

Does DVA or ZBH pay a bigger dividend?

ZBH pays a dividend (0.99% yield), while DVA has no payments in the available dividend history.

Is DVA or ZBH more profitable?

ZBH runs the higher net margin — DVA at 5.65% versus ZBH at 9.05%.

How have DVA and ZBH total returns compared?

Over the past 10 years, DVA delivered 11.88% and ZBH delivered -1.82% annualized total return. Past performance doesn't predict future results.

DaVita Inc. (DVA) vs Zimmer Biomet Holdings, Inc. (ZBH)

A side-by-side comparison of DaVita Inc. and Zimmer Biomet Holdings, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 4, 2026. Differences are shown without an overall score or investment verdict.

DVA

DaVita Inc.

$14.78B

$230.20HealthcareDelayed quote: Aug 4, 2026, 10:55 AM EDT

ZBH

Zimmer Biomet Holdings, Inc.

$18.40B

$95.10HealthcareDelayed quote: Aug 4, 2026, 10:50 AM EDT

Total return — DVA vs ZBH

growth of $100 · dividends reinvested · last 25y

DVA +3123.2%ZBH +280.3%DVA compounded faster

Log scale — wide-divergence pair

DVA ZBH

DVA vs ZBH: by the numbers

•ZBH is the larger company ($18.40B vs $14.78B market cap).
•DVA trades at the lower trailing earnings multiple (23.51 vs 25.19 P/E), one valuation lens rather than an overall verdict.
•ZBH converts more revenue to profit (9.05% vs 5.65% net margin).
•ZBH grew revenue faster over the past five years (4.21% vs 3.71% CAGR).
•ZBH pays a dividend (0.99% yield), while DVA has no payments in the available dividend history.

Metrics side by side

Valuation

Metric	DVA	ZBH
P/E ratio	23.51	25.19
Forward P/E	15.70	11.43
P/S ratio	1.16	2.26
P/B ratio	N/A	1.50
PEG ratio	2.85	N/A
EV / EBITDA	10.23	11.25
FCF yield	9.28%	9.66%

Profitability

Metric	DVA	ZBH
Gross margin	31.10%	61.62%
Operating margin	15.01%	15.61%
Net margin	5.65%	9.05%
ROE	-114.70%	6.01%
ROIC	10.58%	5.48%

Dividends

Metric	DVA	ZBH
Dividend yield	N/A	0.99%
Payout ratio	N/A	26.97%

Growth (annualized)

Metric	DVA	ZBH
Revenue CAGR (5Y)	3.71%	4.21%
EPS CAGR (5Y)	8.25%	N/A
FCF CAGR (5Y)	6.13%	15.41%
Total return CAGR (5Y)	13.67%	-7.45%

Frequently asked

Which has the lower trailing P/E, DVA or ZBH?: DVA has the lower trailing P/E: DVA trades at 23.51 and ZBH at 25.19. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, DVA or ZBH?: Over the past five years, ZBH grew revenue faster — DVA at a 3.71% CAGR versus ZBH at 4.21%.
Does DVA or ZBH pay a bigger dividend?: ZBH pays a dividend (0.99% yield), while DVA has no payments in the available dividend history.
Is DVA or ZBH more profitable?: ZBH runs the higher net margin — DVA at 5.65% versus ZBH at 9.05%.
How have DVA and ZBH total returns compared?: Over the past 10 years, DVA delivered 11.88% and ZBH delivered -1.82% annualized total return. Past performance doesn't predict future results.

Go deeper

Full DVA analysis Full ZBH analysis Interactive comparison tool

Dig into the metrics

DaVita P/E ratio Zimmer Biomet P/E ratio DaVita dividend yield Zimmer Biomet dividend yield DaVita ROE Zimmer Biomet ROE DaVita operating margin Zimmer Biomet operating margin DaVita revenue growth Zimmer Biomet revenue growth DaVita free cash flow Zimmer Biomet free cash flow

DaVita & Zimmer Biomet appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 4, 2026.